Product Overview

To discover novel drug targets and/or severity biomarkers for Multiple Sclerosis, researchers need access to the most complete dataset available. We have curated one of the largest MS datasets, enriched with progressive MS data, comprised of Whole Genome Sequence and detailed longitudinal clinical data of several thousand participants.



To learn more, download the datasheet below: